Washington, DC (October 20, 2021) — Racial and ethnic disparities in pediatric kidney transplantation have been described in multiple studies, but in December 2014, a U.S. policy change was implemented in part to improve equity in access to transplantation. A new study in CJASN has assessed the impact of this policy, called the Kidney Allocation System.
The study by Jill Krissberg, MD, MS (Ann & Robert H. Lurie Children’s Hospital of Chicago/ Northwestern University Feinberg School of Medicine) and her colleagues included children on the U.S. kidney transplant list from 2008 to 2019. The investigators found no racial and ethnic disparities regarding time on the waitlist until transplantation either before or after the 2014 policy change. Racial and ethnic disparities did exist for time on dialysis until transplantation, but these disparities lessened after the 2014 policy change.
“The place that this policy change seemed to have the most effect was it helped make time on dialysis to transplantation even across all racial and ethnic groups when it wasn’t before the policy change took effect. Times were even only after adjusting for patient and transplant related factors—such as blood type, age, where someone lives—meaning there are other factors affecting access to transplant for children of color that still need to be explored,” said Dr. Krissberg. “A finding of our study that was a surprise to us is that children of all racial/ethnic groups waited longer for kidney transplants after this 2014 kidney allocation system change.”
Study authors include Matthew Kaufmann, MHS, Anshal Gupta, MTM, Eran Bendavid, MD, MS, Margaret Stedman, PhD, Xingxing Cheng, MD, MS, Jane Tan, MD, PhD, Paul Grimm, MD, and Abanti Chaudhuri, MD.
Disclosures: The authors reported no relevant financial disclosures.
The article, titled “Racial Disparities in Pediatric Kidney Transplantation Under the New Kidney Allocation System in the United States,” will appear online at http://cjasn.asnjournals.org/ on October 20, 2021, doi: 10.2215/CJN.06740521.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 21,000 members representing 131 countries. For more information, visit www.asn-online.org.
Tracy Hampton email@example.com
Vita Lerman: firstname.lastname@example.org